The global cytotoxic drugs market is on the cusp of remarkable expansion, with projections indicating a substantial increase in market value to USD 18.3 billion by 2033, up from USD 16.3 billion in ...
They include cytotoxic T cells, which are important for killing cancerous or virally infected cells, and CD8-positive suppressor T cells, which restrain certain types of immune response.
Tevogen is driven by a team of experienced industry leaders and scientists with drug development and global product launch experience. Tevogen’s leadership believes that accessible personalized ...